$
7. 70
+0.12
+1.5831%
$
- Market Cap
- Div Yield
1,263 Volume
$ 7.58
Previous Close Want to track IBBD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
iShares Biotechnology ETF (IBBD) Statistics
Valuation metrics
Market Cap -
Enterprise value -8.7B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 0.1
Enterprise Value/Revenue -0.06
Enterprise Value/EBITDA -0.11
Overview
Shares outstanding -
Float 2.18B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 777
Average volume (90 days) 554
Price summary
52-Week low 4.93
52-Week high 8.04
Beta 1.22
50-Day moving average 6.55
200-Day moving average 6.11
Financials
Fiscal year
Fiscal year ends 31 Dec 2023
Most recent quarter (mrq) 31 Dec 2023
Profitability
Profit margin 0.36%
Operating margin 0.43%
Operational effectiveness
Return on assets 0.17%
Return on equity 0.36%
Income Statement
Revenue (ttm) 156.23B
Revenue per share (ttm) 2.15
Quarterly revenue growth (yoy) 0.19%
Gross profit (ttm) 127.33B
EBITDA 79.21B
Net income to common (ttm) 55.54B
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) 0.35%
Balance Sheet
Total cash (mrq) 70.9B
Total cash per share (mrq) 28.09
Total debt (mrq) 49.05B
Total Debt/Equity (mrq) 29.81
Current ratio (mrq) 2.73%
Book value per share (mrq) 65.19
Cash Flow
Cash flow statement 82.74B
Levered free cash flow (LFCF) 39.08B
